×
QQQ   291.63 (+1.53%)
AAPL   140.88 (+0.37%)
MSFT   262.56 (+1.13%)
FB   184.01 (+1.51%)
GOOGL   2,119.89 (+0.02%)
AMZN   2,145.00 (+3.03%)
TSLA   662.28 (+5.43%)
NVDA   168.84 (+4.52%)
BABA   82.71 (+0.29%)
NIO   14.67 (+0.27%)
AMD   92.96 (+1.97%)
CGC   5.04 (+5.88%)
MU   68.32 (+2.55%)
T   21.28 (+0.57%)
GE   74.26 (-0.35%)
F   12.74 (+2.58%)
DIS   103.61 (+1.99%)
AMC   11.69 (+12.51%)
PFE   53.79 (+0.71%)
PYPL   80.05 (+1.78%)
NFLX   187.78 (+4.13%)
QQQ   291.63 (+1.53%)
AAPL   140.88 (+0.37%)
MSFT   262.56 (+1.13%)
FB   184.01 (+1.51%)
GOOGL   2,119.89 (+0.02%)
AMZN   2,145.00 (+3.03%)
TSLA   662.28 (+5.43%)
NVDA   168.84 (+4.52%)
BABA   82.71 (+0.29%)
NIO   14.67 (+0.27%)
AMD   92.96 (+1.97%)
CGC   5.04 (+5.88%)
MU   68.32 (+2.55%)
T   21.28 (+0.57%)
GE   74.26 (-0.35%)
F   12.74 (+2.58%)
DIS   103.61 (+1.99%)
AMC   11.69 (+12.51%)
PFE   53.79 (+0.71%)
PYPL   80.05 (+1.78%)
NFLX   187.78 (+4.13%)
QQQ   291.63 (+1.53%)
AAPL   140.88 (+0.37%)
MSFT   262.56 (+1.13%)
FB   184.01 (+1.51%)
GOOGL   2,119.89 (+0.02%)
AMZN   2,145.00 (+3.03%)
TSLA   662.28 (+5.43%)
NVDA   168.84 (+4.52%)
BABA   82.71 (+0.29%)
NIO   14.67 (+0.27%)
AMD   92.96 (+1.97%)
CGC   5.04 (+5.88%)
MU   68.32 (+2.55%)
T   21.28 (+0.57%)
GE   74.26 (-0.35%)
F   12.74 (+2.58%)
DIS   103.61 (+1.99%)
AMC   11.69 (+12.51%)
PFE   53.79 (+0.71%)
PYPL   80.05 (+1.78%)
NFLX   187.78 (+4.13%)
QQQ   291.63 (+1.53%)
AAPL   140.88 (+0.37%)
MSFT   262.56 (+1.13%)
FB   184.01 (+1.51%)
GOOGL   2,119.89 (+0.02%)
AMZN   2,145.00 (+3.03%)
TSLA   662.28 (+5.43%)
NVDA   168.84 (+4.52%)
BABA   82.71 (+0.29%)
NIO   14.67 (+0.27%)
AMD   92.96 (+1.97%)
CGC   5.04 (+5.88%)
MU   68.32 (+2.55%)
T   21.28 (+0.57%)
GE   74.26 (-0.35%)
F   12.74 (+2.58%)
DIS   103.61 (+1.99%)
AMC   11.69 (+12.51%)
PFE   53.79 (+0.71%)
PYPL   80.05 (+1.78%)
NFLX   187.78 (+4.13%)
NYSEAMERICAN:YCBD

cbdMD (YCBD) Stock Forecast, Price & News

$0.77
-0.04 (-5.00%)
(As of 05/25/2022 02:34 PM ET)
Add
Compare
Today's Range
$0.77
$0.83
50-Day Range
N/A
52-Week Range
$0.56
$3.47
Volume
8,390 shs
Average Volume
282,704 shs
Market Capitalization
$45.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.64
30 days | 90 days | 365 days | Advanced Chart
Receive YCBD News and Ratings via Email

Sign-up to receive the latest news and ratings for cbdMD and its competitors with MarketBeat's FREE daily newsletter.

cbdMD logo

About cbdMD

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.

Headlines

See More Headlines

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Toilet preparations
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:YCBD
CIK
N/A
Fax
N/A
Employees
154
Year Founded
N/A

Sales & Book Value

Annual Sales
$44.48 million
Book Value
$1.35 per share

Profitability

Net Income
$-23.40 million
Pretax Margin
-64.46%

Debt

Price-To-Earnings

Miscellaneous

Free Float
42,025,000
Market Cap
$45.68 million
Optionable
Not Optionable

Company Calendar

Last Earnings
12/16/2021
Today
5/25/2022
Next Earnings (Estimated)
8/10/2022
Fiscal Year End
9/30/2022

MarketRank

Overall MarketRank

2.00 out of 5 stars

Analyst Opinion: 3.0Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -













cbdMD (NYSEAMERICAN:YCBD) Frequently Asked Questions

Is cbdMD a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for cbdMD in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" cbdMD stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in YCBD, but not buy additional shares or sell existing shares.
View analyst ratings for cbdMD
or view top-rated stocks.

When is cbdMD's next earnings date?

cbdMD is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022.
View our earnings forecast for cbdMD
.

How were cbdMD's earnings last quarter?

cbdMD, Inc. (NYSEAMERICAN:YCBD) announced its earnings results on Thursday, December, 16th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.05) by $0.03. The business earned $9.79 million during the quarter. cbdMD had a negative net margin of 64.39% and a negative trailing twelve-month return on equity of 9.28%.
View cbdMD's earnings history
.

What price target have analysts set for YCBD?

1 equities research analysts have issued twelve-month price targets for cbdMD's shares. Their forecasts range from $3.25 to $3.25. On average, they anticipate cbdMD's stock price to reach $3.25 in the next year. This suggests a possible upside of 322.4% from the stock's current price.
View analysts' price targets for cbdMD
or view top-rated stocks among Wall Street analysts.

Who are cbdMD's key executives?
cbdMD's management team includes the following people:
  • Mr. Martin A. Sumichrast, Chairman & Co-CEO (Age 55, Pay $590.18k)
  • Mr. Raymond Scott Coffman, Co-Founder, Pres, Co-CEO & Director (Age 60, Pay $563.29k)
  • Mr. T. Ronan Kennedy, CFO, COO, Sec. & Treasurer (Age 42, Pay $247.12k)
  • Mr. John Weston, Director of Investor Relations
  • Mr. Lance Blundell, Gen. Counsel (Age 51)
  • Robert Pettway, Director of PR
  • Mr. Francisco Mangual, Sr. VP of Sales (Age 43)
  • Mr. Matthew Coapman, Chief Marketing Officer (Age 46)
  • Dr. Sibyl Swift Ph.D., VP for Scientific & Regulatory Affairs (Age 41)
  • Mr. David Johnson, Sr. VP of Bus. Devel. (Age 52)
What other stocks do shareholders of cbdMD own?
What is cbdMD's stock symbol?

cbdMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "YCBD."

Who are cbdMD's major shareholders?

cbdMD's stock is owned by many different institutional and retail investors. Top institutional investors include Mirae Asset Global Investments Co. Ltd. (2.16%), Vanguard Group Inc. (1.98%), AdvisorShares Investments LLC (1.71%), Penserra Capital Management LLC (0.85%), Anchor Capital Advisors LLC (0.25%) and Davy Global Fund Management Ltd (0.22%). Company insiders that own cbdMD stock include Bakari T Sellers, Martin A Sumichrast, Raymond Scott Coffman, Thomas Ronan Kennedy and William F Raines III.
View institutional ownership trends for cbdMD
.

Which major investors are selling cbdMD stock?

YCBD stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Penserra Capital Management LLC, Mirae Asset Global Investments Co. Ltd., swisspartners Ltd., AdvisorShares Investments LLC, Group One Trading L.P., and Simplex Trading LLC.
View insider buying and selling activity for cbdMD
or view top insider-selling stocks.

Which major investors are buying cbdMD stock?

YCBD stock was bought by a variety of institutional investors in the last quarter, including Davy Global Fund Management Ltd, Anchor Capital Advisors LLC, Vident Investment Advisory LLC, and Renaissance Technologies LLC.
View insider buying and selling activity for cbdMD
or or view top insider-buying stocks.

How do I buy shares of cbdMD?

Shares of YCBD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is cbdMD's stock price today?

One share of YCBD stock can currently be purchased for approximately $0.77.

How much money does cbdMD make?

cbdMD has a market capitalization of $45.68 million and generates $44.48 million in revenue each year. The company earns $-23.40 million in net income (profit) each year or ($0.47) on an earnings per share basis.

How many employees does cbdMD have?

cbdMD employs 154 workers across the globe.

What is cbdMD's official website?

The official website for cbdMD is www.cbdmd.com.

How can I contact cbdMD?

cbdMD's mailing address is 8845 Red Oak Boulevard, Charlotte NC, 28217. The company can be reached via phone at (704) 445-3060 or via email at [email protected].

This page was last updated on 5/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.